Last reviewed · How we verify

Short storage RBC age

Washington University School of Medicine · Phase 3 active Biologic

This investigational approach studies the transfusion of red blood cells stored for shorter periods to evaluate clinical outcomes and safety compared to standard storage protocols.

This investigational approach studies the transfusion of red blood cells stored for shorter periods to evaluate clinical outcomes and safety compared to standard storage protocols. Used for Evaluation of short-storage RBC transfusion in critically ill patients, Assessment in perioperative/surgical patient populations.

At a glance

Generic nameShort storage RBC age
SponsorWashington University School of Medicine
ModalityBiologic
Therapeutic areaHematology / Transfusion Medicine
PhasePhase 3

Mechanism of action

Red blood cell storage lesion—biochemical and functional changes that occur during standard blood bank storage—may be mitigated by using fresher RBCs. This Phase 3 study investigates whether transfusing RBCs stored for shorter durations reduces adverse clinical outcomes, organ dysfunction, and mortality in critically ill or surgical patients compared to conventional storage practices.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: